Handbook of Clinical medicine

new randomized trials. Patients benefi t directly from a tiny fraction of these papers. How do we fi nd them? • A hierarchy of evidence (fi g 1.3) is used to identify the best research available to answer our question. • Specialist EBM journals, eg Evidence-based Med- icine, appraise published information for quality, relevance, and interest on our behalf. • The Cochrane Collabora- tion gathers and summa- rizes best evidence, free from commercial spon- sorship and confl icts of Fig 1.3 Hierarchy of evidence. interest. >37 000 research- EBM Pyramid and EBM Page Generator, copyright 2006 Trustees of ers from 130 countries Dartmouth College and Yale University. contribute. Problems: • The concept of scientifi c rigour is opaque. What do we want? The science, the rigour, the truth, or what will be most useful to patients? These may overlap, but they are not the same. Can average cohort results inform clinical decisions on an individual level (especially in the context of comorbidity)? • Can we really appraise ALL the evidence? 27 We are hindered by publication bias. Around half of all clinical trials remain unpublished. See www.alltrials.net for the cam- paign to register all trials, and ensure methods and summary
